131 related articles for article (PubMed ID: 8219659)
1. Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.
Nowack R; Fliser D; Richter J; Horne C; Mutschler E; Ritz E
Clin Investig; 1993 Aug; 71(8):622-7. PubMed ID: 8219659
[TBL] [Abstract][Full Text] [Related]
2. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
[TBL] [Abstract][Full Text] [Related]
3. The effects of cilazapril alone and in combination with frusemide in healthy subjects.
Johnston GD; Passmore AP
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):235S-242S. PubMed ID: 2527536
[TBL] [Abstract][Full Text] [Related]
4. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension.
Fliser D; Nowack R; Wolf G; Ritz E
Blood Press; 1993 Dec; 2(4):296-300. PubMed ID: 8173699
[TBL] [Abstract][Full Text] [Related]
6. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
Anderson PJ; Critchley JA; Tomlinson B
Eur J Clin Pharmacol; 1996; 50(1-2):57-62. PubMed ID: 8739812
[TBL] [Abstract][Full Text] [Related]
8. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and renal effects of cilazapril and their reversal by angiotensin in renovascular hypertensive rats.
Ding YA; Chang ST; Shieh SM; Huang WC
Clin Sci (Lond); 1988 Apr; 74(4):365-72. PubMed ID: 2965632
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary salt and angiotensin-converting enzyme inhibitor on ATP-driven Ca pump and Na/Ca exchange in aortic rings of Dahl rats.
Ashida T; Yoshimi H; Kawano Y; Matsuoka H; Omae T
Clin Exp Hypertens; 1996 Aug; 18(6):851-71. PubMed ID: 8842567
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin converting enzyme inhibition on renal response to atrial natriuretic factor in rats.
Wu JN; Huang WC
Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):186-93. PubMed ID: 2977443
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of angiotensin II in normotensive subjects on short-term cilazapril treatment.
Hannedouche T; Ikeni A; Marques LP; Natov S; Dechaux M; Schmitt F; Lacour B; Grünfeld JP
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S25-7. PubMed ID: 1382161
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
17. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE
J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034
[TBL] [Abstract][Full Text] [Related]
18. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the actions of cilazapril in normal, dietary sodium-depleted and two-kidney, one clip Goldblatt hypertensive anaesthetised rats.
al-Qattan KK; Johns EJ
J Hypertens; 1992 May; 10(5):423-9. PubMed ID: 1317902
[TBL] [Abstract][Full Text] [Related]
20. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]